CRL
Price
$193.14
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
14 days until earnings call
NEOG
Price
$14.02
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
62 days until earnings call
Ad is loading...

CRL vs NEOG

Header iconCRL vs NEOG Comparison
Open Charts CRL vs NEOGBanner chart's image
Charles River Laboratories International
Price$193.14
Change-$0.00 (-0.00%)
Volume$448.19K
CapitalizationN/A
Neogen
Price$14.02
Change-$0.00 (-0.00%)
Volume$1.9M
CapitalizationN/A
View a ticker or compare two or three
CRL vs NEOG Comparison Chart
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRL vs. NEOG commentary
Oct 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a StrongBuy and NEOG is a Buy.

COMPARISON
Comparison
Oct 16, 2024
Stock price -- (CRL: $193.87 vs. NEOG: $14.02)
Brand notoriety: CRL and NEOG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 86% vs. NEOG: 131%
Market capitalization -- CRL: $13.96B vs. NEOG: $3.42B
CRL [@Medical Specialties] is valued at $13.96B. NEOG’s [@Medical Specialties] market capitalization is $3.42B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 0 FA rating(s) are green whileNEOG’s FA Score has 1 green FA rating(s).

  • CRL’s FA Score: 0 green, 5 red.
  • NEOG’s FA Score: 1 green, 4 red.
According to our system of comparison, CRL is a better buy in the long-term than NEOG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 4 TA indicator(s) are bullish while NEOG’s TA Score has 4 bullish TA indicator(s).

  • CRL’s TA Score: 4 bullish, 4 bearish.
  • NEOG’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRL is a better buy in the short-term than NEOG.

Price Growth

CRL (@Medical Specialties) experienced а +3.77% price change this week, while NEOG (@Medical Specialties) price change was -5.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

CRL is expected to report earnings on Feb 12, 2025.

NEOG is expected to report earnings on Dec 17, 2024.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($14B) has a higher market cap than NEOG($3.42B). NEOG has higher P/E ratio than CRL: NEOG (150.80) vs CRL (29.15). CRL YTD gains are higher at: -17.991 vs. NEOG (-30.283). CRL has higher annual earnings (EBITDA): 1.03B vs. NEOG (189M). CRL has more cash in the bank: 277M vs. NEOG (230M). NEOG has less debt than CRL: NEOG (889M) vs CRL (3.07B). CRL has higher revenues than NEOG: CRL (4.13B) vs NEOG (919M).
CRLNEOGCRL / NEOG
Capitalization14B3.42B410%
EBITDA1.03B189M546%
Gain YTD-17.991-30.28359%
P/E Ratio29.15150.8019%
Revenue4.13B919M449%
Total Cash277M230M120%
Total Debt3.07B889M345%
FUNDAMENTALS RATINGS
CRL vs NEOG: Fundamental Ratings
CRL
NEOG
OUTLOOK RATING
1..100
560
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
6289
PRICE GROWTH RATING
1..100
6160
P/E GROWTH RATING
1..100
503
SEASONALITY SCORE
1..100
48n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRL's Valuation (74) in the Miscellaneous Commercial Services industry is in the same range as NEOG (96) in the Medical Specialties industry. This means that CRL’s stock grew similarly to NEOG’s over the last 12 months.

CRL's Profit vs Risk Rating (77) in the Miscellaneous Commercial Services industry is in the same range as NEOG (100) in the Medical Specialties industry. This means that CRL’s stock grew similarly to NEOG’s over the last 12 months.

CRL's SMR Rating (62) in the Miscellaneous Commercial Services industry is in the same range as NEOG (89) in the Medical Specialties industry. This means that CRL’s stock grew similarly to NEOG’s over the last 12 months.

NEOG's Price Growth Rating (60) in the Medical Specialties industry is in the same range as CRL (61) in the Miscellaneous Commercial Services industry. This means that NEOG’s stock grew similarly to CRL’s over the last 12 months.

NEOG's P/E Growth Rating (3) in the Medical Specialties industry is somewhat better than the same rating for CRL (50) in the Miscellaneous Commercial Services industry. This means that NEOG’s stock grew somewhat faster than CRL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLNEOG
RSI
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 2 days ago
47%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 27 days ago
67%
Declines
ODDS (%)
Bearish Trend 8 days ago
64%
Bearish Trend 8 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
56%
Aroon
ODDS (%)
Bearish Trend 2 days ago
66%
N/A
View a ticker or compare two or three
Ad is loading...
CRL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X66046.1250003194.750000
+5.08%
Bitcoin cryptocurrency
GME21.330.50
+2.40%
GameStop Corp
AAPL231.403.85
+1.69%
Apple
SPY584.324.74
+0.82%
SPDR® S&P 500® ETF Trust
TSLA219.161.36
+0.62%
Tesla

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with CRL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
-2.84%
CRL - NEOG
46%
Loosely correlated
+0.09%
AZTA - NEOG
45%
Loosely correlated
+0.51%
VCYT - NEOG
43%
Loosely correlated
-0.26%
CERS - NEOG
41%
Loosely correlated
+3.85%
ICUI - NEOG
41%
Loosely correlated
+0.97%
More